ARCHIVED: NOT AVAILABLE FOR CREDIT
Update on HPV Testing

 

This talk will provide an overview of the biology and epidemiology of high-risk HPV infections and summarize concepts and performance of available cervical cancer screening tests. An update on recent changes to screening guidelines will be provided.

Originally presented on February 6, 2017, in Park City, Utah.

Lecture Presenter

Robert Schlaberg, MD, Dr Med, MPH

Robert Schlaberg, MD, Dr Med, MPH

Assistant Professor of Pathology
University of Utah School of Medicine
Medical Director, Microbial Amplified Detection, Virology, and Fecal Chemistry Laboratories and Assistant Medical Director, Virology and Molecular Infectious Disease Laboratories
ARUP Laboratories

Dr. Schlaberg is an assistant professor of clinical pathology at the University of Utah School of Medicine. He received his MD and doctor medicinæ degrees at the Julius-Maximilians-University in Wuerzburg, Germany and his master of public health at the Mailman School of Public Health at Columbia University in New York City, where he also served as a postdoctoral fellow. Dr. Schlaberg trained in clinical pathology at the Columbia University College of Physicians & Surgeons, where he was the chief clinical pathology resident. He is certified in clinical pathology and medical microbiology by the American Board of Pathology. His research focuses on the use of next-generation sequencing for unbiased pathogen detection and host response-based diagnostics.

Objectives

After this presentation, participants will be able to:

  • Understanding the biology and epidemiology of HR HPV
  • Understanding the performance of available cervical cancer screening tests
  • Reviewing recent changes to screening guidelines

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories